The Song of the Cell: a cancer doctor on what a cell is

The Song of the Cell: An Exploration of Medicine and the New Human is a work of popular science. It was published in 2022. Its author, Siddhartha Mukherjee, is a physician and writer. He also wrote an earlier book, The Emperor of All Maladies, about the history of cancer.

This later book is not a cancer history. Its subject is the cell itself. It asks what a cell is. It asks how the discipline of cell biology developed. And it asks how understanding cells has reshaped medicine across many diseases. Cancer is one of those diseases.

The book moves between three modes: historical narrative, laboratory science, and Mukherjee's own clinical experience as an oncologist. Cancer comes up again and again. It is not the book's central subject, though. It is one of the clearest examples of what happens when a cell's normal controls fail. Other sections cover neurons, immune cells, stem cells, and reproductive cells.

It assumes an interested general reader rather than a scientist. Even so, it does not simplify the biology. Some readers want a plain description of what a cancer cell actually is, in mechanical terms. They will get one here. It sits inside a much larger argument about the cell as the basic unit of medicine.

The book is organized into parts built around cell types and functions, not around diseases. Some sections cover the history of cell theory itself. Others move through blood cells and immunity, then neurons and the brain, then stem cells and regeneration, then reproductive and embryonic cells.

Cancer material appears throughout rather than in one contained section. Cancer cells come up where the book covers what happens when a cell's growth signals go wrong. They come up again where it covers cell-based cancer treatments. One of those is CAR T-cell therapy. That treatment engineers a patient's own immune cells. The cells are changed to recognize and destroy cancer cells.

There is no patient case built around one person's cancer diagnosis, the way a memoir would have one. Mukherjee draws on patients he has treated as an oncologist. But the book's structure is organized around the science, not around any single illness story.

The book includes extensive notes and a bibliography. That reflects its grounding in the scientific and historical literature Mukherjee draws on. It is not built on personal narrative alone.

The book's strength is explanatory. It takes genuinely difficult cell biology and lays it out for a reader with no scientific background. It does that without removing the substance.

Some parts describe what makes a cancer cell behave differently from a normal cell. Others describe how modern treatments like immunotherapy exploit cell biology directly.

The historical sections are also strong. The book traces cell theory from its origins in microscopy. It follows the story through the rise of modern molecular biology. That gives context for cell-based treatments like CAR T-cell therapy. It shows why they represent a genuinely new category of medicine, not an incremental step.

The book was written and published in 2022. Cell-based cancer treatment is one of the fastest-moving areas of oncology. So specific drugs, trial results, and approval statuses in the book have moved on since publication. They have moved in both directions. Some experimental approaches described as promising have since been approved for wider use. Others have not advanced as expected.

The book is a work of science writing, not a clinical reference. It does not carry treatment guidance or dosing information. It sets out no eligibility criteria for any therapy it discusses. It should not be read as a substitute for information from a person's own oncology team. That team knows what is currently available for their specific cancer.

Cancer appears throughout the book rather than in one section. So a reader looking specifically for cancer content will need to read more of the book than its title might suggest, to assemble the full picture.

The book discusses cell-based cancer treatment as a genuinely new therapeutic category. It sets it apart from older approaches like chemotherapy and radiation. Those target dividing cells in general, rather than specific molecular or cellular features.

NCI's own current overview is called "Types of Cancer Treatment." It lists the same broad categories a reader of the book would recognize. Chemotherapy works by killing or stopping the growth of cancer and other fast-growing cells. Targeted therapy aims at specific changes in cancer cells that help them grow and spread. Immunotherapy is described as helping a patient's own immune system fight cancer. The list also includes radiation therapy, surgery, hormone therapy, and stem cell transplant.

NCI's page on what cancer is at the cellular level covers the same biological picture. The book explains it at greater length. NCI describes cancer as arising from a buildup of mutations across three types of genes. Proto-oncogenes can drive uncontrolled growth when overactive. Tumor suppressor genes normally restrain growth. And DNA repair genes fix damaged DNA. NCI also lists cellular hallmarks of cancer cells. They match the book's descriptions closely. Cancer cells grow without external growth signals. They invade nearby tissue. They recruit blood vessels to feed the tumor. And they evade immune detection.

NCI describes the path some tissues take toward cancer in stages. In hyperplasia, cells are more numerous but still look normal. In dysplasia, cells look abnormal but have not invaded nearby tissue. And in cancer itself, cells invade. That staged model fits the cell-biology framing the book uses throughout.

Some readers want a plain-language account of cancer written for patients rather than general readers. For that, see breast cancer screening. It and the broader NCI material behind it cover the clinical use of the same biology. The book explains that biology historically and scientifically. For the symptom side, when a cell's abnormal growth first becomes noticeable to a patient, see cancer symptoms. Readers who want the deeper molecular detail behind this book's science can see the biology of cancer. That is the university-level textbook this book's science ultimately draws on.

This book suits a reader who wants to understand cancer at the level of the cell. The same goes for medicine generally. It also asks for patience with a long work of science writing.

It does not suit a reader who wants immediate, usable information about their own diagnosis or treatment options. It is not organized as a reference. It does not answer "what does this mean for me" questions. A reader in that position should start with material written directly for patients, such as NCI's own disease-specific pages. They can return to this book afterward, if the underlying biology still interests them.

We keep Cancer Explained free and ad-free for everyone. If this page was useful, consider supporting it.

• NCI — What Is Cancer?
• NCI — Types of Cancer Treatment

This page discusses The Song of the Cell for education. It is not medical advice, and nothing here is a judgement of anyone's real medical care.